<DOC>
	<DOCNO>NCT01293955</DOCNO>
	<brief_summary>- A Pilot study - Randomized Double-blinded - Placebo control - In 2 parallel group ( JOINS 200mg : Placebo = 1:1 ) - Overall 24 month treatment ( JOINS : Placebo comparison 12 month , Additional follow-up assessment 24 month ) - Provide rescue medicine throughout whole clinical trial period .</brief_summary>
	<brief_title>Assessment Protective Effect JOINS Cartilage Knee Osteoarthritis</brief_title>
	<detailed_description>1 . Assessment Efficacy 1 . Knee MRI ( Magnetic resonance imaging ) : - Assessment cartilage volume , thickness target knee - GAG ( glycosaminoglycan ) concentration target knee - Assessment Whole-Organ Magnetic Resonance Imaging Score ( WORMS ) target knee 2 . Knee radiography : - Assessment change minimal medial JSW ( Joint Space Width ) target knee . 3 . Knee pain ( VAS ) - Assessment change pain target knee . 4 . K-WOMAC ( Western Ontario McMaster Universities Osteoarthritis Index Korean ) - Assessment score change pain ( 5 question ) , stiffness ( 2 question ) physical function ( 17 question ) . - The questionnaire self-administered patient . 5 . Used frequency rescue medicine . 6 . Biochemical cartilage bone marker - Blood urine sample collect morning night fast period since 10 pm previous day avoid variation . 2 . Assessment Safety 1 . Adverse event 2 . Laboratory assessment 3 . Vital sign 4 . 12-lead ECG 5 . Physical examination 3 . Enrollment : 76</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . A female eligible : Nonchild bear potential ( i.e. , physiologically incapable become pregnant ) , include female least 2 year post menopausal Child bear potential agrees acceptable contraceptive method use consistently correctly Pregnancy test result negative screening 2 . Primary Knee OA ( Osteoarthritis ) medial femorotibial compartment base ACR ( American College Rheumatology ) Criteria . ACR Criteria : With Knee pain satisfy least 1 3 ( ① age &gt; 50 year , morning stiffness &lt; 30 minute , ③ Presence Crepitus Osteophytes motion ) 3 . Appropriately sign date informed consent obtain 1 . Rheumatoid arthritis inflammatory arthritis . 2 . Bilateral total knee replacement already treat , plan procedure . 3 . Knee prosthesis already implant , foreseen within next year . 4 . Clinically significant hip osteoarthritis . 5 . Severe renal insufficiency define creatinine clearance &lt; 30ml/mln ( Cockcroft formula ) . 6 . Clinically significant pulmonary , hepatic , renal heart disorder diagnosis crucial disease investigator ( Glycosuria ( Diabetes mellitus ) asthma patient exclude clinical study patient clinically significant disease also excluded. ) . 7 . MRI contraindication : overweight , inferior limb diameter nonfitting knee antenna , insert pacemaker , metallic prosthesis ( know interfere MRI procedure know unsafe MRI ) , metallic clip , insulin pump , cytostatic pump , hear aid , essential tremor , claustrophobia , etc , . 8 . Allergic reaction Clinical trial medication . 9 . Other clinical trial drug 1 month prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>cartilage</keyword>
	<keyword>knee osteoarthritis</keyword>
	<keyword>protective effect</keyword>
</DOC>